G2/M arrest through ataxia telangiectasia and Rad3 related (ATR)/checkpoint kinase 1 (CHK1) arrest is crucial since the majority of tumors with KRAS mutations also harbor TP53 mutations, as shown in pancreatic ductal carcinomas [42]. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.